amiodarone has been researched along with Choked Disk in 18 studies
Amiodarone: An antianginal and class III antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting POTASSIUM CHANNELS and VOLTAGE-GATED SODIUM CHANNELS. There is a resulting decrease in heart rate and in vascular resistance.
amiodarone : A member of the class of 1-benzofurans that is 1-benzofuran substituted by a butyl group at position 2 and a 4-[2-(diethylamino)ethoxy]-3,5-diiodobenzoyl group at position 3. It is a cardiovascular drug used for the treatment of cardiac dysrhythmias.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We described two cases with papilledema within the first months of amiodarone treatment." | 4.84 | [Amiodarone associated optic neuropathies--two cases reports]. ( Andris, C; Collignon, N; Van Elmbt, G, 2007) |
| "Disc swelling and hemorrhages appeared in three eyes of two men receiving amiodarone hydrochloride for cardiac arrhythmias." | 3.67 | Papillopathy caused by amiodarone. ( Asdourian, GK; Gittinger, JW, 1987) |
| "Amiodarone is an excellent antiarrhythmic medication; however, it has numerous systemic and ocular adverse effects." | 2.66 | Ocular Adverse Effects of Amiodarone: A Systematic Review of Case Reports. ( Alshehri, M; Joury, A, 2020) |
| " After ruling out intracranial hypertension, arteritic ischemic optic neuropathy, non-arteritic, and inflammatory bilateral papilledema, the diagnosis was toxic optic neuropathy." | 1.51 | [Amiodarone-induced optic neuropathy: A rare side effect]. ( Ambrosi, P; Arcani, R; Arnould, T; Chagny, M; Daumas, A; Gayet, S; Gobin, N; Micallef, J; Pellerey, M; Rouby, F; Scapin, J; Villani, P, 2019) |
| "Amiodarone is a commonly prescribed and one of the most effective anti-arrhythmic drugs available." | 1.39 | Bilateral optic neuropathy and permanent loss of vision after treatment with amiodarone. ( Falck, A; Hautala, N; Hurskainen, M; Kervinen, M, 2013) |
| "Amiodarone was discontinued and the optic disc edema completely resolved over 15 months." | 1.33 | Regression of bilateral optic disc edema after discontinuation of amiodarone. ( Frohman, LP; Shinder, R; Turbin, RE, 2006) |
| "Amiodarone therapy was then discontinued, but there was no considerable improvement and after 6 weeks visual loss occurred in the left eye as well." | 1.31 | [First unilateral, later bilateral optic neuropathy. Amiodarone as the cause?]. ( Gerke, E; Uebermuth, CA, 2002) |
| "Optic neuropathy has been reported to occur during antiarrhythmic therapy with amiodarone." | 1.31 | [Amiodarone-associated optic neuropathy: an independent syndrome? Three patients with bilateral optic neuropathy]. ( Gerling, J; Hansen, LL; Leifert, D, 2000) |
| "Amiodarone has been used for the last 20 years, initially as antianginal and then as antiarrhythmic agent." | 1.28 | [Optic neuropathy caused by amiodarone]. ( Ferreiro, JL; Isern Longares, JA; Ramón Moya, AF, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (11.11) | 18.7374 |
| 1990's | 4 (22.22) | 18.2507 |
| 2000's | 8 (44.44) | 29.6817 |
| 2010's | 3 (16.67) | 24.3611 |
| 2020's | 1 (5.56) | 2.80 |
| Authors | Studies |
|---|---|
| Arcani, R | 1 |
| Pellerey, M | 1 |
| Rouby, F | 1 |
| Gobin, N | 1 |
| Scapin, J | 1 |
| Chagny, M | 1 |
| Arnould, T | 1 |
| Ambrosi, P | 1 |
| Gayet, S | 1 |
| Micallef, J | 1 |
| Villani, P | 1 |
| Daumas, A | 1 |
| Alshehri, M | 1 |
| Joury, A | 1 |
| Kervinen, M | 1 |
| Falck, A | 1 |
| Hurskainen, M | 1 |
| Hautala, N | 1 |
| Le-Nguyen, XT | 1 |
| Lee, TK | 1 |
| Do, DV | 1 |
| Sepah, YJ | 1 |
| Nguyen, QD | 1 |
| Rao, NA | 1 |
| Vasconcelos-Santos, DV | 1 |
| Goldstein, DA | 1 |
| Uebermuth, CA | 1 |
| Gerke, E | 1 |
| Aït Ali, F | 1 |
| Grolleau-Raoux, F | 1 |
| Arnaud, B | 1 |
| Schmitt-Bernard, CF | 1 |
| Charles, PE | 1 |
| Doise, JM | 1 |
| Quenot, JP | 1 |
| Muller, G | 1 |
| Aube, H | 1 |
| Baudouin, N | 1 |
| Piard, F | 1 |
| Besancenot, JF | 1 |
| Blettery, B | 1 |
| Shinder, R | 1 |
| Frohman, LP | 1 |
| Turbin, RE | 1 |
| Van Elmbt, G | 1 |
| Andris, C | 1 |
| Collignon, N | 1 |
| Borruat, FX | 1 |
| Regli, F | 1 |
| Gobbelé, R | 1 |
| Dahlke, C | 1 |
| Mull, M | 1 |
| Schwarz, M | 1 |
| Sreih, AG | 1 |
| Schoenfeld, MH | 1 |
| Marieb, MA | 1 |
| Speicher, MA | 1 |
| Goldman, MH | 1 |
| Chrousos, GA | 1 |
| Leifert, D | 1 |
| Hansen, LL | 1 |
| Gerling, J | 1 |
| Kristin, N | 1 |
| Ulbig, M | 1 |
| Ferreiro, JL | 1 |
| Isern Longares, JA | 1 |
| Ramón Moya, AF | 1 |
| Gittinger, JW | 2 |
| Asdourian, GK | 2 |
3 reviews available for amiodarone and Choked Disk
| Article | Year |
|---|---|
Ocular Adverse Effects of Amiodarone: A Systematic Review of Case Reports.
Topics: Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Case-Control Studies; Corneal Diseases; | 2020 |
[Amiodarone associated optic neuropathies--two cases reports].
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Humans; Male; Papilledema | 2007 |
[Amiodarone-induced bilateral optic atrophy--a case report].
Topics: Aged; Amiodarone; Female; Humans; Optic Atrophy; Papilledema; Prednisolone; Sick Sinus Syndrome; Tre | 1999 |
15 other studies available for amiodarone and Choked Disk
| Article | Year |
|---|---|
[Amiodarone-induced optic neuropathy: A rare side effect].
Topics: Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Female; Humans; Iatrogenic Disease; Optic Ner | 2019 |
Bilateral optic neuropathy and permanent loss of vision after treatment with amiodarone.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Blindness; Female; Humans; Optic Nerve Diseases; Papillede | 2013 |
Diagnostic and therapeutic challenges.
Topics: Adult; Amiodarone; Central Nervous System Diseases; Diagnosis, Differential; Glucocorticoids; Humans | 2011 |
[First unilateral, later bilateral optic neuropathy. Amiodarone as the cause?].
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Blindness; Dose-Response Relationshi | 2002 |
[Amiodarone and disk edema: physiopathological debate based on a case report].
Topics: Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Humans; Male; Papilledema | 2003 |
Amiodarone-related acute respiratory distress syndrome following sudden withdrawal of steroids.
Topics: Adrenal Cortex Hormones; Aged; Amiodarone; Anti-Arrhythmia Agents; Bronchoalveolar Lavage Fluid; Fat | 2006 |
Regression of bilateral optic disc edema after discontinuation of amiodarone.
Topics: Amiodarone; Female; Follow-Up Studies; Humans; Middle Aged; Myocardial Infarction; Papilledema; Subs | 2006 |
Pseudotumor cerebri as a complication of amiodarone therapy.
Topics: Amiodarone; Atrial Fibrillation; Fundus Oculi; Humans; Male; Middle Aged; Papilledema; Pseudotumor C | 1993 |
Optic neuropathy following amiodarone therapy.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Dose-Response Relationship, Drug; Follow-Up Studies; Human | 1999 |
Amiodarone optic neuropathy without disc edema.
Topics: Amiodarone; Anti-Arrhythmia Agents; Humans; Male; Middle Aged; Optic Nerve; Optic Nerve Diseases; Pa | 2000 |
[Amiodarone-associated optic neuropathy: an independent syndrome? Three patients with bilateral optic neuropathy].
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Diagnosis, Differential; Humans; Male; Middle Aged; Optic | 2000 |
[Acute papilledema. A 69-year-old patient with acute bilateral papilledema].
Topics: Acute Disease; Aged; Amiodarone; Anti-Arrhythmia Agents; Follow-Up Studies; Humans; Male; Papilledem | 2001 |
[Optic neuropathy caused by amiodarone].
Topics: Amiodarone; Animals; Cardiac Complexes, Premature; Demyelinating Diseases; Humans; Male; Middle Aged | 1990 |
Amiodarone-related optic neuropathy.
Topics: Amiodarone; Humans; Papilledema | 1988 |
Papillopathy caused by amiodarone.
Topics: Amiodarone; Arrhythmias, Cardiac; Drug Therapy, Combination; Eye Hemorrhage; Humans; Male; Middle Ag | 1987 |